T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$2.34B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$1.33B |
| 3 |
Alibaba
BABA
|
+$983M |
| 4 |
Intuit
INTU
|
+$932M |
| 5 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.8B |
| 2 |
Tesla
TSLA
|
+$1.74B |
| 3 |
NXP Semiconductors
NXPI
|
+$1.24B |
| 4 |
Danaher
DHR
|
+$1.21B |
| 5 |
Booking.com
BKNG
|
+$1.09B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.78% |
| 2 | Financials | 16.36% |
| 3 | Consumer Discretionary | 14.69% |
| 4 | Technology | 14.23% |
| 5 | Industrials | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Patrick Industries
PATK
$2.78B
| $29.5M | 0.01% |
911,835
+39,870
| +5% | +$1.24M |
|
1027
Carlisle Companies
CSL
$14.9B
| $29.5M | 0.01% |
308,997
+4,412
| +1% | +$446K |
|
1028
Box
BOX
$4.66B
| $29.4M | 0.01% |
1,614,599
+1,528,582
| +1,777% | +$27.6M |
|
1029
ResMed
RMD
$32.9B
| $29.4M | 0.01% |
376,921
-51,083
| -12% | -$3.65M |
|
1030
Bio-Rad Laboratories Class A
BIO
$9.66B
| $29.3M | 0.01% |
129,399
-1,975
| -2% | -$430K |
|
1031
Freeport-McMoran
FCX
$93.6B
| $29.2M | 0.01% |
2,430,429
-1,212,848
| -33% | -$14.7M |
|
1032
Synaptics
SYNA
$4.2B
| $29.1M | 0.01% |
562,033
+18,258
| +3% | +$996K |
|
1033
Zumiez
ZUMZ
$319M
| $29M | 0.01% |
2,345,716
-796,290
| -25% | -$12.2M |
|
1034
Arthur J. Gallagher & Co
AJG
$65B
| $28.9M | 0.01% |
503,932
-28,691
| -5% | -$1.62M |
|
|
ARCH
1035
DELISTED
Arch Resources, Inc.
ARCH
| $28.8M | 0.01% |
421,337
-929,265
| -69% | -$65.3M |
|
|
AIMT
1036
DELISTED
Aimmune Therapeutics
AIMT
| $28.7M | 0.01% |
1,396,399
+227,627
| +19% | +$4.34M |
|
1037
Lincoln National
LNC
$8.67B
| $28.5M | 0.01% |
421,481
+916
| +0.2% | +$60.6K |
|
1038
Choice Hotels
CHH
$4.71B
| $28.5M | 0.01% |
443,147
-272,497
| -38% | -$17.5M |
|
1039
Quest Diagnostics
DGX
$26.1B
| $28.4M | 0.01% |
255,930
-30,623
| -11% | -$3.24M |
|
1040
Labcorp
LH
$26.2B
| $28.4M | 0.01% |
214,586
+736
| +0.3% | +$90.1K |
|
1041
Lindblad Expeditions
LIND
$2.26B
| $28.4M | 0.01% |
2,706,121
+16,900
| +0.6% | +$160K |
|
1042
Conduent
CNDT
$252M
| $28.4M | 0.01% |
1,779,343
+464,202
| +35% | +$7.6M |
|
|
FOLD
1043
DELISTED
Amicus Therapeutics
FOLD
| $28.3M | 0.01% |
2,814,841
-26,989
| -0.9% | -$217K |
|
1044
Wynn Resorts
WYNN
$10.5B
| $28.3M | 0.01% |
210,933
-13,373
| -6% | -$1.68M |
|
1045
Fastenal
FAST
$58.9B
| $28.1M | 0.01% |
2,579,860
-56,000
| -2% | -$629K |
|
|
EDR
1046
DELISTED
Education Realty Trust Inc
EDR
| $28M | 0.01% |
723,482
+668,102
| +1,206% | +$26.1M |
|
|
SRUNU
1047
DELISTED
Silver Run Acquisition Corporation II Units
SRUNU
| $28M | 0.01% |
2,623,720
-855,500
| -25% | -$8.92M |
|
1048
Ligand Pharmaceuticals
LGND
$5.76B
| $27.9M | 0.01% |
369,038
+16,138
| +5% | +$1.13M |
|
|
WDR
1049
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $27.9M | 0.01% |
1,479,634
+226,496
| +18% | +$3.98M |
|
|
SIX
1050
DELISTED
Six Flags Entertainment Corp.
SIX
| $27.8M | 0.01% |
467,104
-659
| -0.1% | -$39.9K |
|
Similar funds
T. Rowe Price Associates's Q2 2017 Portfolio in Review
As of Q2 2017, T. Rowe Price Associates held 2,638 positions worth $556B, up 4.2% from $534B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q2 2017 filing shows 69 new, 1,185 increased, 969 reduced and 83 closed positions. Its largest new stake was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M. The largest sale was Amazon, an estimated $1.8B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2017, an estimated $2.34B increase.
- T. Rowe Price Associates's biggest Q2 2017 reduction was Amazon, cutting an estimated $1.8B.
- T. Rowe Price Associates fully exited Yahoo Inc in Q2 2017, selling an estimated $362M.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $556B portfolio in Q2 2017.
- T. Rowe Price Associates opened 69 new positions and closed 83 in Q2 2017.
- T. Rowe Price Associates's portfolio value rose 4.2% quarter-over-quarter to $556B.
Based on T. Rowe Price Associates's 13F filing for Q2 2017, filed 14 Aug 2017.